These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

401 related articles for article (PubMed ID: 31038755)

  • 1. Fecal Microbial Transplant Capsules Are Safe in Hepatic Encephalopathy: A Phase 1, Randomized, Placebo-Controlled Trial.
    Bajaj JS; Salzman NH; Acharya C; Sterling RK; White MB; Gavis EA; Fagan A; Hayward M; Holtz ML; Matherly S; Lee H; Osman M; Siddiqui MS; Fuchs M; Puri P; Sikaroodi M; Gillevet PM
    Hepatology; 2019 Nov; 70(5):1690-1703. PubMed ID: 31038755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microbial functional change is linked with clinical outcomes after capsular fecal transplant in cirrhosis.
    Bajaj JS; Salzman N; Acharya C; Takei H; Kakiyama G; Fagan A; White MB; Gavis EA; Holtz ML; Hayward M; Nittono H; Hylemon PB; Cox IJ; Williams R; Taylor-Robinson SD; Sterling RK; Matherly SC; Fuchs M; Lee H; Puri P; Stravitz RT; Sanyal AJ; Ajayi L; Le Guennec A; Atkinson RA; Siddiqui MS; Luketic V; Pandak WM; Sikaroodi M; Gillevet PM
    JCI Insight; 2019 Dec; 4(24):. PubMed ID: 31751317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fecal microbiota transplant from a rational stool donor improves hepatic encephalopathy: A randomized clinical trial.
    Bajaj JS; Kassam Z; Fagan A; Gavis EA; Liu E; Cox IJ; Kheradman R; Heuman D; Wang J; Gurry T; Williams R; Sikaroodi M; Fuchs M; Alm E; John B; Thacker LR; Riva A; Smith M; Taylor-Robinson SD; Gillevet PM
    Hepatology; 2017 Dec; 66(6):1727-1738. PubMed ID: 28586116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Randomized Clinical Trial of Fecal Microbiota Transplant for Alcohol Use Disorder.
    Bajaj JS; Gavis EA; Fagan A; Wade JB; Thacker LR; Fuchs M; Patel S; Davis B; Meador J; Puri P; Sikaroodi M; Gillevet PM
    Hepatology; 2021 May; 73(5):1688-1700. PubMed ID: 32750174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fecal Microbiota Transplant in Cirrhosis Reduces Gut Microbial Antibiotic Resistance Genes: Analysis of Two Trials.
    Bajaj JS; Shamsaddini A; Fagan A; Sterling RK; Gavis E; Khoruts A; Fuchs M; Lee H; Sikaroodi M; Gillevet PM
    Hepatol Commun; 2021 Feb; 5(2):258-271. PubMed ID: 33553973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibiotic-Associated Disruption of Microbiota Composition and Function in Cirrhosis Is Restored by Fecal Transplant.
    Bajaj JS; Kakiyama G; Savidge T; Takei H; Kassam ZA; Fagan A; Gavis EA; Pandak WM; Nittono H; Hylemon PB; Boonma P; Haag A; Heuman DM; Fuchs M; John B; Sikaroodi M; Gillevet PM
    Hepatology; 2018 Oct; 68(4):1549-1558. PubMed ID: 29665102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fecal microbiota transplant improves cognition in hepatic encephalopathy and its effect varies by donor and recipient.
    Bloom PP; Donlan J; Torres Soto M; Daidone M; Hohmann E; Chung RT
    Hepatol Commun; 2022 Aug; 6(8):2079-2089. PubMed ID: 35384391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gut Microbiota Modulation and Fecal Transplantation: An Overview on Innovative Strategies for Hepatic Encephalopathy Treatment.
    Hassouneh R; Bajaj JS
    J Clin Med; 2021 Jan; 10(2):. PubMed ID: 33477417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preliminary experience with single fecal microbiota transplant for treatment of recurrent overt hepatic encephalopathy-A case series.
    Mehta R; Kabrawala M; Nandwani S; Kalra P; Patel C; Desai P; Parekh K
    Indian J Gastroenterol; 2018 Nov; 37(6):559-562. PubMed ID: 30474827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Faecal microbiota transplantation for diarrhoea-predominant irritable bowel syndrome: a double-blind, randomised, placebo-controlled trial.
    Aroniadis OC; Brandt LJ; Oneto C; Feuerstadt P; Sherman A; Wolkoff AW; Kassam Z; Sadovsky RG; Elliott RJ; Budree S; Kim M; Keller MJ
    Lancet Gastroenterol Hepatol; 2019 Sep; 4(9):675-685. PubMed ID: 31326345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of Fecal Microbiota Transplantation With Oral Capsules in Obese Patients.
    Allegretti JR; Kassam Z; Mullish BH; Chiang A; Carrellas M; Hurtado J; Marchesi JR; McDonald JAK; Pechlivanis A; Barker GF; Miguéns Blanco J; Garcia-Perez I; Wong WF; Gerardin Y; Silverstein M; Kennedy K; Thompson C
    Clin Gastroenterol Hepatol; 2020 Apr; 18(4):855-863.e2. PubMed ID: 31301451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gut microbiota: its role in hepatic encephalopathy.
    Rai R; Saraswat VA; Dhiman RK
    J Clin Exp Hepatol; 2015 Mar; 5(Suppl 1):S29-36. PubMed ID: 26041954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and preliminary efficacy of orally administered lyophilized fecal microbiota product compared with frozen product given by enema for recurrent Clostridium difficile infection: A randomized clinical trial.
    Jiang ZD; Jenq RR; Ajami NJ; Petrosino JF; Alexander AA; Ke S; Iqbal T; DuPont AW; Muldrew K; Shi Y; Peterson C; Do KA; DuPont HL
    PLoS One; 2018; 13(11):e0205064. PubMed ID: 30388112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple bacterial virulence factors focused on adherence and biofilm formation associate with outcomes in cirrhosis.
    Bajaj JS; Shamsaddini A; Acharya C; Fagan A; Sikaroodi M; Gavis E; McGeorge S; Khoruts A; Fuchs M; Sterling RK; Lee H; Gillevet PM
    Gut Microbes; 2021; 13(1):1993584. PubMed ID: 34743650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral, frozen fecal microbiota transplant (FMT) capsules for recurrent Clostridium difficile infection.
    Youngster I; Mahabamunuge J; Systrom HK; Sauk J; Khalili H; Levin J; Kaplan JL; Hohmann EL
    BMC Med; 2016 Sep; 14(1):134. PubMed ID: 27609178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroinflammation in Murine Cirrhosis Is Dependent on the Gut Microbiome and Is Attenuated by Fecal Transplant.
    Liu R; Kang JD; Sartor RB; Sikaroodi M; Fagan A; Gavis EA; Zhou H; Hylemon PB; Herzog JW; Li X; Lippman RH; Gonzalez-Maeso J; Wade JB; Ghosh S; Gurley E; Gillevet PM; Bajaj JS
    Hepatology; 2020 Feb; 71(2):611-626. PubMed ID: 31220352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intestinal Microbiome Changes in Fecal Microbiota Transplant (FMT)
    Garza-González E; Mendoza-Olazarán S; Morfin-Otero R; Ramírez-Fontes A; Rodríguez-Zulueta P; Flores-Treviño S; Bocanegra-Ibarias P; Maldonado-Garza H; Camacho-Ortiz A
    Can J Gastroenterol Hepatol; 2019; 2019():4549298. PubMed ID: 31976311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of microbiota in hepatic encephalopathy.
    Bajaj JS
    Gut Microbes; 2014; 5(3):397-403. PubMed ID: 24690956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PROFIT, a PROspective, randomised placebo controlled feasibility trial of Faecal mIcrobiota Transplantation in cirrhosis: study protocol for a single-blinded trial.
    Woodhouse CA; Patel VC; Goldenberg S; Sanchez-Fueyo A; China L; O'Brien A; Flach C; Douiri A; Shawcross D
    BMJ Open; 2019 Feb; 9(2):e023518. PubMed ID: 30772848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fecal microbiota transplantation in hepatic encephalopathy: a systematic review.
    Madsen M; Kimer N; Bendtsen F; Petersen AM
    Scand J Gastroenterol; 2021 May; 56(5):560-569. PubMed ID: 33840331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.